Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Spaceflight, genetic tinkering, and the psychological implications of technological acceleration are explored with accuracy ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...